Statistics for Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease
Total visits
views | |
---|---|
Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease | 149 |
Total visits per month
views | |
---|---|
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
File Visits
views | |
---|---|
CNS-21-513.pdf | 124 |
java.util.UUID:c728c319-eda4-4dfc-8df8-5dd8881cc3a1 | 63 |
java.util.UUID:b46acd06-88bd-4652-ac81-c3ac2b70fd8c | 13 |
java.util.UUID:cf7edf10-437f-4bd7-8128-5393d5fd7c66 | 6 |
Top country views
views | |
---|---|
United States | 115 |
China | 4 |
Germany | 4 |
Ukraine | 4 |
United Kingdom | 3 |
Canada | 2 |
Denmark | 1 |
India | 1 |
Morocco | 1 |
Malaysia | 1 |
Russia | 1 |
Uzbekistan | 1 |
Top city views
views | |
---|---|
Wilmington | 48 |
Houston | 13 |
Fairfield | 12 |
Baltimore | 6 |
Cambridge | 5 |
Jacksonville | 5 |
Kiev | 4 |
Ann Arbor | 3 |
Kiez | 3 |
Brooklyn | 2 |
Toronto | 2 |
Washington | 2 |
Aarhus | 1 |
Beijing | 1 |
Bengaluru | 1 |
Casablanca | 1 |
Dearborn | 1 |
Gunzenhausen | 1 |
Hefei | 1 |
Moscow | 1 |
Phoenix | 1 |
San Francisco | 1 |
Scottsdale | 1 |
Seremban | 1 |
Tashkent | 1 |
Zhongyuan | 1 |